In another example of the "obesity paradox," a long-term study of 10,568 type 2 diabetes patients found that participants who were overweight were 13% less likely to die than participants who had normal BMI’s or were obese. The researchers speculated that being overweight may help type 2 diabetes patients avoid …
Read More »Lowering A1c Reduces Risk of Diabetes-related Eye Surgery
A new study revealed that just a 10% improvement in A1C levels led to a 35% lower risk of undergoing diabetes-related eye surgery for type 1 diabetes patients, and intensive management reduced the risk even more, by nearly 50%. New England Journal of Medicine
Read More »Quitting Smoking Deteriorates Diabetes Control
According to new research, type 2 diabetes patients who quit smoking are likely to see a temporary deterioration in their glycemic control which could last up to three years. They examined the primary care records of 10,692 adult smokers with T2DM over six years to investigate whether or not quitting …
Read More »Type 2 Diabetes Screening Doesn’t Lower Mortality Rates
After 10 years of follow-up, type 2 diabetes screening is not associated with improved mortality rates. The investigators conducted a systematic literature review using data from Cochrane databases and MEDLINE, and relevant studies from previous task force reviews. Screening for diabetes correlated with no 10-year mortality benefit versus no screening …
Read More »Diabetes before 26th Week of Pregnancy Linked to Higher Risk for Autism
Children whose mothers were diagnosed with diabetes by the 26th week of pregnancy had a 42% increased risk of being diagnosed with autism, according to a study. Diabetes after 26 weeks of pregnancy and type 2 diabetes before conception were not associated with increased autism risk. JAMA April 14, 2015, …
Read More »Combo Drug Glyxambi Now Available – One Pill, One Co-pay
Combo Drug Glyxambi is a combination of empagliflozin and linagliptin in a tablet form for adults with type 2 diabetes. Both empagliflozin, an SGLT-2, and linagliptin, a DPP-4 inhibitor, are already on the market separately. Glyxambi’s main benefit is combining two different diabetes drugs into a single pill (in this …
Read More »Parental Diabetes May Predict Glycemic Control in Young Diabetes Patients
Children with type 2 diabetes had worse glycemic control, more hypertension and higher BMI’s when their parents had diabetes, hypertension and obesity, according to new research. Researchers looked at 699 children with type 2 diabetes and found that those whose parents had diabetes had higher baseline A1C levels and were …
Read More »Diabetes Patients Face Higher Health Cost and Reduced Life Span
A study in Diabetes Care found fewer life years and greater health care expenses linked to diabetes. For individuals with diabetes, the predicted life expectancy had an inverted U-shape for most BMI classifications, with overweight individuals having the highest life years lost. Higher lifelong health costs were seen in whites and …
Read More »Curbing Atrial Fibrillation with Weight Loss in Obese People
Australian researchers found a higher odds of eliminating symptoms of atrial fibrillation in obese patients who lost at least 10% of their body weight without undergoing surgery or medication than in those who failed to lose weight. The findings were presented at the American College of Cardiology meeting. — Journal …
Read More »Estimated Costs of Endocrine-Disrupting Chemical Exposure Exceed $209 Billion Annually in EU
A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union $209 billion a year in actual health care expenses and lost earning potential, according to a new series of studies. Global experts in this field concluded that infertility and male reproductive dysfunctions, birth defects, obesity, diabetes, …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.